The main purpose of REVHD is to evaluate the therapeutic potential of Resveratrol on the caudate volume (area located near the center of the brain) in Huntington’s disease (HD) patients, using volumetric MRI. This trial aims to test for a reduction in neurodegeneration among HD patients.